Improved Treatment For Many Patients With HER2-Positive Breast Cancer

[News]

Combining targeted therapies might be required for maximum anti-tumor activity when treating HER2-positive breast cancers, according to two new studies by Vanderbilt-Ingram Cancer Center (VICC) investigators...

More... (http://www.medicalnewstoday.com/articles/218598.php)